Trump Allies’ Children and Niblings Cash in on Lobbying Boom
The next generation of Trumpworld lobbyists are landing major clients and scoring policy wins.
The next generation of Trumpworld lobbyists are landing major clients and scoring policy wins.
The Blue Dog Coalition, a group of self-described fiscal conservatives led by Rep. Marie Gluesenkamp Perez (D-WA), largely voted for the GOP-crafted bill pushing defense spending above $1 trillion.
California water ratepayers are funding lobbyists who simultaneously represent chemical companies that oppose PFAS regulation.
The firm, which employed Attorney General Pam Bondi and other Trump administration officials as lobbyists, saw its lobbying revenue skyrocket by 300% year-over-year.
Some Republicans in a bipartisan group of House lawmakers have given the speaker until the end of the month to bring a new unified bill to the floor, or they vow to force a vote.
The Speaker and his Republican colleagues met with Israeli settlers as momentum builds for an Israeli annexation of the West Bank.
Last month, the super PAC backing Andrew Cuomo received $1.3 million in one week from billionaire heirs and an oil & gas CEO, readying to spend in the New York City mayoral election against progressive Zohran Mamdani.
Pfizer, Merck, Eli Lilly and other drug giants are spending record amounts on lobbying as they fight the Trump administration on vaccine policies and more.
Nvidia announced a record $60 billion stock buyback, following plans by corporations like Apple and Alphabet that are likely to boost their own stock prices.
House Democratic Caucus Chair Pete Aguilar, Steny Hoyer, and other senior lawmakers have directed millions to the controversial fundraising firm, even after years of reporting on its predatory tactics.